- Company Directors - F
- Federico Charles
Insider Trading History of Federico Charles
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Federico Charles since 2006.
The trader's CIK number is 1213215.
At the time of the last reporting, Federico Charles was the Director of Biomimetic Therapeutics, Inc.. (stock ticker symbol BMTI).
Also see all insider trading activities at Biomimetic Therapeutics, Inc..
Note that in the past
FEDERICO CHARLES also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biomimetic Therapeutics, Inc. (BMTI) by Federico Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | BMTI | 0 | $0 | 0 | $0 | 38,736 | $163,272 |
| 2008 | BMTI | 1,075 | $9,936 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mako Surgical Corp. (MAKO) by Federico Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | MAKO | 2,000 | $25,898 | 0 | $0 | 0 | $0 |
| 2008 | MAKO | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sri Surgical Express Inc (STRC) by Federico Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | STRC | 5,000 | $20,339 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Orthofix Medical Inc. (OFIX) by Federico Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | OFIX | 0 | $0 | 299,400 | $12,121,822 | 299,400 | $7,934,715 |
Yearly summary of insider trading at Power Medical Interventions, Inc. (PMII) by Federico Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | PMII | 3,000 | $11,466 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Federico Charles:
1. Biomimetic Therapeutics, Inc. (BMTI)
2. Mako Surgical Corp. (MAKO)
3. Sri Surgical Express Inc (STRC)
4. Orthofix Medical Inc. (OFIX)
5. Power Medical Interventions, Inc. (PMII)
Table 1. Insider trading of Biomimetic Therapeutics, Inc. (BMTI) by Federico Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-03-01 | BMTI | Option Ex | 38,736 | 4.21 | 163,272 |
| 2008-03-28 | BMTI | Buy | 1,075 | 9.24 | 9,936 |
Table 2. Insider trading of Mako Surgical Corp. (MAKO) by Federico Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-08-03 | MAKO | Buy | 2,000 | 12.95 | 25,898 |
| 2008-02-20 | MAKO | Buy | 10,000 | 10.00 | 100,000 |
Table 3. Insider trading of Sri Surgical Express Inc (STRC) by Federico Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-05-13 | STRC | Buy | 5,000 | 4.07 | 20,339 |
Table 4. Insider trading of Orthofix Medical Inc. (OFIX) by Federico Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-12-05 | OFIX | Option Ex | 43,800 | 40.40 | 1,769,520 |
| 2006-12-05 | OFIX | Sale | 43,800 | 45.10 | 1,975,248 |
| 2006-08-30 | OFIX | Option Ex | 125,100 | 17.88 | 2,236,162 |
| 2006-08-31 | OFIX | Option Ex | 124,900 | 30.66 | 3,828,934 |
| 2006-08-30 | OFIX | Sale | 125,100 | 39.82 | 4,981,356 |
| 2006-08-31 | OFIX | Sale | 124,900 | 39.41 | 4,922,558 |
| 2006-03-08 | OFIX | Option Ex | 2,500 | 17.88 | 44,687 |
| 2006-03-08 | OFIX | Sale | 2,500 | 43.00 | 107,500 |
| 2006-03-03 | OFIX | Sale | 3,100 | 43.60 | 135,160 |
| 2006-03-03 | OFIX | Option Ex | 3,100 | 17.88 | 55,412 |
Table 5. Insider trading of Power Medical Interventions, Inc. (PMII) by Federico Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-08-18 | PMII | Buy | 3,000 | 3.82 | 11,466 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Federico Charles
(Director of Biomimetic Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.